ConclusionInfluenza induced cardiogenic shock is extremely rare and most reported cases are due to fulminant myocarditis associated with influenza A virus5. Though, the significance of influenza B virus may have been underestimated, as its infection is generally considered to be mild, with less associated cardiovascular involvement in adults6.
- World Health Organization (WHO). Vaccines against influenza WHO position paper - November 2012. Wkly Epi-demiol Rec 2012; 87:461-76.
- Kuiken T, Taubenberger JK. Pathology of human influenza revisited. Vaccine 2008; 26 (Suppl 4):D59-66.
- Mamas MA, Fraser D, Neyses L: Cardiovascular manifestations associated with influenza virus infection. Int J Cardiol 2008; 130:304-309.
- Dec GW Jr, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, Johnson RA: Active myocarditis in the spectrum of acute dilated ardiomyopathies: clinical features, histologic correlates, and clinical outcome. N Engl J Med 1985; 312:885-90.
- Ukimura A, Ooi Y, Kanzaki Y, Inomata T, Izumi T: A national survey on myocarditis associated with influenza H1N1pdm2009 in the pandemic and postpandemic season in Japan. J Infect Chemother 2013; 19:426–431.
- Paddock CD, Liu L, Denison AM, Bartlett JH, Holman RC, Deleon-Carnes M, Emery SL, Drew CP, Shieh WJ, Uyeki TM, Zaki SR: Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis 2012; 205:895–905.